Home  |  About Us  |  News and Press  |  Subsidiaries  |  Investors  |  Contact
  Phage International               Discovery and Rediscovery

Phage Therapy Center

About Phage Therapy Clinics My Diagnosis Become a Patient

wpe5D.jpg (3370 bytes)

  Infections
  My Diagnosis

  Clinics
  Drug Resistance

Phage Therapy Center Georgia is accepting patients with diabetic foot ulcers, tropic ulcers, bed sores, and osteomyelitis -- including those with drug-resistant VRE and MRSA infections.
     Bronchopneumonia, Empyema
Pneumonia is an inflammation of the lung caused by infection with bacteria, viruses, and other organisms. Pneumonia is usually triggered when a patient's defense system is weakened, most often by a simple viral upper respiratory tract infection or a case of influenza. Such infections or other triggers do not cause pneumonia directly but they alter the mucous blanket, thus encouraging bacterial growth. Other factors can also make specific people susceptible to bacterial growth and pneumonia.

Phage Therapy

Etiology:
Staphylococcus aureus, Escherichia coli, Klebsiella, Proteus, Pseudomonas

Phage Therapy Center
Phage Therapy Center treats antibiotic-resistant infections.  [More information...]


Additional Information About Phage Therapy for This Condition

Evergreen State College
Polish Update

Hirzfield Institute of Immunology and Virology
Therapeutic Use of Bacteriophages in Bacterial Infections

Hirzfield Institute of Immunology and Virology
Efficacy of Phage Therapy - Clinical Trials

Eliava Institute
List of Bacteriophages


Medical Information

March 10, 2003
Common Drug-Resistant Bacteria Spreading
The drugs used to treat some of the most common illnesses, such as ear infections, meningitis, sinusitis, and pneumonia, may soon lose their effectiveness as the bacteria responsible for these infections are quickly becoming resistant to popular antibiotics.

July, 2002
Treatment of drug-resistant pneumococcal pneumonia
The increasing prevalence of resistance to penicillin and other drugs among pneumococci has considerably complicated the empirical treatment of community-acquired pneumonia. Penicillin resistance has become widespread and is a worldwide occurrence. Resistance to other classes of antibiotics traditionally used as alternatives in the treatment of pneumococcal infections has also increased markedly during recent years.

May 1, 2002
Community-acquired Pneumonia due to Drug-resistant Streptococcus pneumoniae
Antimicrobial resistance in Streptococcus pneumoniae has progressed at a disturbing rate. Approximately one-third of pneumococci exhibit reduced susceptibility to penicillin.

August 6, 1999
Drug-resistant pneumonia bacteria on the rise
The bacteria that cause pneumonia, meningitis and other serious illnesses are becoming increasingly resistant to penicillin, federal health officials said.

More Information / Questions / Comments

Privacy Policy ~ Legal Notices

Copyright © PhageInternational, Inc. 2004-2005 ~ All Rights Reserved
2010 Crow Canyon Place, Suite 100  ~  San Ramon, CA 94583  ~   925-984-9446